WestEnd Advisors’s DexCom DXCM Stock Holding History

WestEnd Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.04K	Hold	12	–	–	﹤0.01%	291
2026 Q2	$808	Buy	12 +2	+20%	+$133	﹤0.01%	302
2026 Q1	$628	Hold	10	–	–	﹤0.01%	293
2025 Q4	$664	Sell	10 -2	-17%	-$129	﹤0.01%	285
2025 Q3	$807	Sell	12 -4	-25%	-$317	﹤0.01%	262
2025 Q2	$1.4K	Buy	16 +1	+7%	+$78	﹤0.01%	187
2025 Q1	$1.02K	Buy	15 +10	+200%	+$816	﹤0.01%	209
2024 Q4	$389	Hold	5	–	–	﹤0.01%	202
2024 Q3	$335	Hold	5	–	–	﹤0.01%	231
2024 Q2	$567	Sell	5 -1	-17%	-$126	﹤0.01%	153
2024 Q1	$832	Hold	6	–	–	﹤0.01%	122
2023 Q4	$745	Buy	6 +1	+20%	+$102	﹤0.01%	127
2023 Q3	$467	Buy	+5	New	+$564	﹤0.01%	159
2023 Q1	–	Sell	-5	Closed	-$560	–	143
2022 Q4	$566	Hold	5	–	–	﹤0.01%	139
2022 Q3	$0	Hold	5	–	–	﹤0.01%	190
2022 Q2	$372	Buy	+5	New	+$456	﹤0.01%	153
2022 Q1	–	Sell	-4	Closed	-$438	–	149
2021 Q4	$536	Buy	+4	New	+$575	﹤0.01%	151
2021 Q3	–	Hold	0	–	–	–	140
2021 Q2	–	Hold	0	–	–	–	162

Other funds holding DXCM

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

WestEnd Advisors's DXCM Position: Q3 2026 in Review

WestEnd Advisors held its DexCom (DXCM) position steady in Q3 2026 at 12 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #291.

WestEnd Advisors first reported a position in DXCM in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.4K in Q2 2025. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

WestEnd Advisors held 12 shares of DexCom worth $1.04K as of Q3 2026.
WestEnd Advisors left its DexCom share count unchanged in Q3 2026.
DexCom made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #291 holding.
WestEnd Advisors first reported a position in DexCom in Q4 2021 and has held it in 17 quarters since.
WestEnd Advisors's DexCom position peaked at $1.4K in Q2 2025.
620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.